243007 ⎘
Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance
SYSTEMS AND METHODS FOR IMPROVED IN VIVO ANALYTE SENSOR FUNCTION
#2Method for altering the binding specificity of plasma proteins by oxidation
#3IgE CH3 peptide vaccine
#4Methods for treating chronic obstructive pulmonary disease
#5C(epsilon)mX peptides for inducing immune responses to human mIgE on B lymphocytes
#6Anti-CεmX antibodies capable of binding to human mIgE on B lymphocytes
#7Methods, compositions and kits relating to chitnases and chitnase-like molecules and inflammation disease
#8Method of altering the binding specificity of plasma proteins by oxidation-reduction
#9Multimeric Fc receptor polypeptides
#10Anti-IGE Vaccines
#11Reducing the immunogenicity of fusion proteins
#12Human antibodies that bind human TNFα
#13Anti-CεmX antibodies capable of binding to human mIgE on B lymphocytes
#14Human antibodies that bind human TNFα and methods of using same
#15Method of identifying membrane Ig specific antibodies and use thereof for targeting immunoglobulin-producing precursor cells
#16METHOD TO INHIBIT AIRWAY HYPERRESPONSIVENESS USING AEROSOLIZED T CELL RECEPTOR ANTIBODIES
#17Methods of administering PIF agonist peptides and uses thereof
#18Methods for treating chronic obstructive pulmonary disease
#19Methods for treating IgE-mediated disorder
#20Methods, products and treatments for diabetes
#21Therapeutic Agents
#22IgE CH3 peptide vaccine
#23Method for the detection of endometriosis using an ME-2 antigen
#24Methods and compositions for inhibiting binding of IgE to a high affinity receptor
#25METHOD OF TREATING IMMUNE DISEASE USING B-CELL ANTIBODIES
#26Method of detecting endometriosis in human subjects using SEQ ID No. 9 or an epitope thereof
#27Methods for treating Chronic Obstructive Pulmonary Disease
#28Methods and compositions for inhibiting binding of IgE to a high affinity receptor
#29THERAPEUTIC AGENTS
#30Anti-IgE vaccines
#31MULTIMERIC Fc RECEPTOR POLYPEPTIDES INCLUDING A MODIFIED Fc DOMAIN
#32Methods of diagnosing endometriosis in human subjects using the ME-5 polypeptide
#33Reducing the immunogenicity of fusion proteins
#34Human antibodies that bind human TNFα
#35Allergenic proteins of natural rubber latex, their production and use in assays
#36Methods to treating chronic obstructive pulmonary disease
#37Methods, products and treatments for diabetes
#38Modified mite allergen and pharmaceutical uses thereof
#39METHODS, COMPOSITIONS, AND KITS RELATING TO CHITINASES AND CHITINASE-LIKE MOLECULES AND INFLAMMATORY DISEASE
#40Methods, compositions, and kits relating to chitinases and chitinase-like molecules and inflammatory disease
#41Methods, compositions, and kits relating to chitinases and chitinase-like molecules and inflammatory disease
#42MODIFIED FUSION MOLECULES FOR TREATMENT OF ALLERGIC DISEASE
#43Method of identifying membrane IgE specific antibodies and use thereof for targeting IgE producing precursor cells
#44PIF peptides biologic activities, site of action, and the antibody to detect PIF
#45Allergy vaccines and their preparation
#46Method of altering the binding specificity of plasma proteins by oxidation-reduction reactions
#47Non-anaphylactic forms of grass pollen Ph1 p 6 allergen and their use
#48ME-5, ME-2, and EPP2: human protein antigens reactive with autoantibodies present in the serum of women suffering from endometriosis
#49Method for isolating and purifying grass pollen allergens
#50Method for isolating and purifying grass pollen allergens
#51Modified mite allergen and pharmaceutical uses thereof
#52Fusion protein for treatment of allergic diseases
#53Multimeric Fc receptor polypeptides
#54Method of detecting allergen
#55METHODS OF USING AN EQUINE FC EPSILON RECEPTOR ALPHA CHAIN PROTEIN
#56ME-5, ME-2, and EPP2: human protein antigens reactive with autoantibodies present in the serum of women suffering from endometriosis
#57Nucleic acid molecules encoding a novel ectoparasite saliva protein
#58Peptide epitopes recognized by disease promoting CD4+ T lymphocytes
#59Methods of treating diseases with activated protein C
#60ME-5, ME-2, and EPP2: human protein antigens reactive with autoantibodies present in the serum of women suffering from endometriosis
#61Feline immunoglobulin E molecules and related methods
#62Peptide epitopes recognized by disease promoting CD4+ T lymphocytes
#63Receptor specific transepithelial transport of therapeutics
#64Methods, products and treatments for diabetes
#65Method for treating established spontaneous auto-immune diseases in mammals
#66Modified fusion molecules for treatment of allergic disease
#67Polypeptides capable of forming antigen binding structures with specificity for the Rhesus D antigens, the DNA encoding them and the process for their preparation and use
#68Deletion forms of IGE-dependent histamine releasing factor having histamine releasing activity, HRF-binding peptides and the uses thereof
#69Methods for the prevention against or treatment of diabetes with ETXB and/or insulin
#70Method of affecting a function of or ablating a non-malignant cell
#71Methods, compositions and kits relating to chitinases and chitinase-like molecules and inflammatory disease
#72Anti-IgE vaccines
#73Reducing the immunogenicity of fusion proteins
#74Human antibodies that bind human TNFα
#75ME-5, ME-2, and EPP2: human protein antigens reactive with autoantibodies present in the serum of women suffering from endometriosis
#76Anti-CD40CR MR1 antibody
#77Polypeptides capable of forming antigen binding structures with specificity for the Rhesus D antigens, the DNA encoding them and the process for their preparation and use
#78Nucleic acid molecules encoding a house dust mite allergen Der f VII, and antigenic peptides thereof
#79Methods for the treatment of inflammatory joint disease
#80Equine Fc epsilon receptor alpha protein
#81Composition for inducing humoral anergy to an immunogen comprising a T cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic valency platform molecule
#82Method of altering the binding specificity of plasma proteins by oxidation-reduction reactions
#83Antibodies against T cells as therapeutics
#84Expression library immunization
#85Allergenic proteins of natural rubber latex, their production and use in assays
#86Composition for inducing humoral anergy to an immunogen comprising a T cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic valency platform molecule